Page last updated: 2024-10-31

minoxidil and Cancer of Prostate

minoxidil has been researched along with Cancer of Prostate in 2 studies

Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.

Research Excerpts

ExcerptRelevanceReference
"Four normal and 79 human prostate cancer (Pca) specimens were examined, by immunohistochemistry, for expression of voltage-gated potassium ion channels."1.31Expression and activity of potassium ion channels in human prostate cancer. ( Abdul, M; Hoosein, N, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, CL1
Liu, JS1
Lin, AC1
Yang, CH1
Chung, WH1
Wu, WG1
Abdul, M1
Hoosein, N1

Other Studies

2 other studies available for minoxidil and Cancer of Prostate

ArticleYear
Minoxidil may suppress androgen receptor-related functions.
    Oncotarget, 2014, Apr-30, Volume: 5, Issue:8

    Topics: Antihypertensive Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mino

2014
Expression and activity of potassium ion channels in human prostate cancer.
    Cancer letters, 2002, Dec-01, Volume: 186, Issue:1

    Topics: Anti-Arrhythmia Agents; Apoptosis; Diazoxide; Dose-Response Relationship, Drug; Humans; Immunohistoc

2002